Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMBRISENTAN vs AMBROXOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMBRISENTAN vs AMBROXOL: Safety Overview

Metric AMBRISENTAN AMBROXOL
Total FAERS Reports 86,197 906
Deaths Reported 10,291 55
Death Rate 11.9% 6.1%
Hospitalizations 32,910 441
Average Patient Age 59.5 yrs 57.8 yrs
% Female Patients 76.1% 53.0%
FDA Approval Date Apr 10, 2019 N/A
Manufacturer Sigmapharm Laboratories, LLC N/A
Route ORAL N/A
Marketing Status Prescription N/A